+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Israel Hair Loss Treatments (Haircare) Market Size, Growth and Forecast Analytics, 2024-2029

  • PDF Icon

    Report

  • 18 Pages
  • June 2026
  • Region: Israel
  • GlobalData
  • ID: 6101220
Israel Hair Loss Treatments (Haircare) Market Size, Growth and Forecast Analytics, 2024-2029 is a broad level market review of Hair Loss Treatments market in Israel.

Includes only those which restore or correct hair loss (male-pattern baldness), excludes general hair tonics and cosmetic hair thickening products which do not entail any physiological change. Applied topically, these products stimulate hair growth, but only for as long as they are used. These products will typically contain minoxidil.

Hair Loss Treatments market in Israel registered a positive compound annual growth rate (CAGR) of 3.26% during the period 2019 to 2024 with a sales value of ILS 1.98 Million in 2024, an increase of 3.98% over 2023. The market achieved its strongest performance in 2023, when it grew by 4.78% over its previous year and its weakest performance in 2020, when it increased by 0.70% over 2019.
The research handbook provides up-to-date market size data for period 2019-2024 and illustrative forecast to 2029, covering key market aspects like Sales Value and Volume for Hair Loss Treatments and its variants .

Furthermore, the research handbook details market sales by Distribution Channel (Dollar Stores, Variety Store & General Merchandise Retailers, Cash & Carries and Warehouse Clubs, Convenience Stores & Gas Stations, Department Stores, Drug Stores & Pharmacies, Chemists/Pharmacies, Parapharmacies/Drugstores, eRetailers, Food & Drinks Specialists, Health & Beauty Stores, Hypermarkets & Supermarkets, Direct Sellers, Others, On Trade, Vending Machines, Other Specialist Retailers, Tobacco Specialists) where ever applicable.

Due to on going large scale uncertainties in the market the research handbook acts as an essential tool for companies active or planning to venture in to Israel's Hair Loss Treatments (Haircare) market. The comprehensive statistics within the research handbook provides insight into the operating environment of the market and also ensures right business decision making based on historical trends and industry model based forecasting.

Sales Values in the handbook are depicted in USD ($) and local currency of country and Volumes are represented in M Units.

*Note: Certain content / sections in the research handbook may be removed or altered based on the availability and relevance of data.

Scope

  • Overall Hair Loss Treatments (Haircare) market value and volume analytics with growth analysis from 2019 to 2029.
  • Distribution channel sales analytics from 2021-2024.

Reasons to Buy

  • Get access to authoritative and granular data on the Hair Loss Treatments (Haircare) market and fill in the gaps in understanding of trends and the components of change behind them.
  • Enhance your understanding of the market to update your strategic and tactical plans based on volume and value changes,distribution trends.
  • Analyze the components of change in the market by looking at historic and future growth patterns.
  • Use the data to understand future patterns of the market trends from winners and losers to category dynamics and thereby quickly and easily identify the key areas in which you want to compete in the future.

Table of Contents

1 Table of Contents
1.1 Contents
1.2 Report Scope
1.3 List of Tables and Figures
1.4 Abbreviations
2 Key Findings
3 Disease Landscape
3.1 Disease Overview
3.2 Epidemiology Overview
3.3 Treatment Overview
4 Marketed Drugs Assessment
4.1 Leading Marketed Drugs
4.2 Overview of Drugs by Approval and Drug Type
4.3 Overview of Drugs by Molecule Type
4.4 Overview of Drugs by MOA
4.5 Product Profile and Sales Forecast
5 Unmet need6 Pricing and Reimbursement Assessment
7 Pipeline Drugs Assessment
7.1 Pipeline Drugs
7.2 Overview by Development Stage
7.3 Overview by Mechanism of Action
7.4 Overview by Molecule Type
7.5 Product Profile and Sales Forecast
7.6 Drug-specific PTSR and LoA
7.7 Indication-specific and Therapy Area-specific PTSR and LoA
8 Clinical Trials Assessment
8.1 Historical Overview
8.2 Overview by Phase
8.3 Overview by Status
8.4 Overview by Phase for Ongoing and Planned Trials
8.5 Trials with Virtual Components
8.6 Top 20 Biomarkers by Trial Phase
8.7 Overview of Trials by Geography
8.8 Single-Country and Multinational Trials by Region
8.9 Top 20 Sponsors with Breakdown by Phase
8.10 Top 20 Sponsors with Breakdown by Status
8.11 Overview by Endpoint Status
8.12 Overview by Race and Ethnicity
8.13 Enrollment Data
8.14 Top 20 countries for Trial Sites
8.15 Top 20 Sites Globally
8.16 Feasibility Analysis - Geographic Overview
8.17 Feasibility Analysis - Benchmark Models
9 Deals Landscape
9.1 Mergers, Acquisitions, and Strategic Alliances by Region
9.2 Recent Mergers, Acquisitions, and Strategic Alliances
10 Commercial Assessment
10.1 Key Market Players
11 Future Market Catalysts
12 Appendix
12.1 Methodology
12.2 Methodology - Sales Forecast
12.3 Methodology - Pricing and Reimbursement
12.4 Methodology - PTSR and LoA Analysis
12.5 About the Authors
12.6 Contact the Publisher
12.7 Disclaimer